stockrowVeeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
- Revenue
- +17.6%
- EPS
- +36.6%
- Free cash flow
- −0.62%
Quarter to July 2026, against a year earlier
Follow VEEV
Alert me
Veeva Systems Inc. (VEEV) Return on assets
Veeva Systems Inc.'s return on assets over the twelve months to 31 July 2026 was 11.9%, up 0.8 percentage points from fiscal 2026 (11.1%). Over the past ten years it has ranged from 8.70% (fiscal 2016) to 15.9% (fiscal 2019); the current reading is higher than 50% of that period. That is above the Health Information Services industry median of −5.62% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 11.1% | 0.36 |
| FY2025 | 10.8% | 0.97 |
| FY2024 | 9.81% | (1.50) |
| FY2023 | 11.3% | (1.15) |
| FY2022 | 12.5% | (1.83) |
| FY2021 | 14.3% | (1.05) |
| FY2020 | 15.3% | (0.60) |
| FY2019 | 15.9% | 1.86 |
| FY2018 | 14.1% | 4.52 |
| FY2017 | 9.56% | 0.86 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| HNGE Hinge Health Inc. compare | 14.1% |
| DOCS Doximity, Inc. compare | 11.9% |
| VEEV Veeva Systems Inc. | 11.9% |
| HQY HealthEquity, Inc. compare | 7.07% |
| BTSG BrightSpring Health Services, Inc. compare | 6.66% |
| WAY Waystar Holding Corp. compare | 2.53% |
| PRVA Privia Health Group, Inc. compare | 2.38% |
| TEM Tempus AI, Inc. compare | −8.00% |
| HTFL Heartflow, Inc. compare | −47.0% |
| Health Information Services industry median | −5.62% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement